Last reviewed · How we verify

NCT03902119

INYBI Tool in Chronic Neck Pain

Completed NA Last updated 29 October 2019
What this trial tests

NA trial testing INYBI tool in Neck Pain in 58 participants. Completed in 27 September 2019.

Timeline
24 April 2019
Primary endpoint
27 September 2019
27 September 2019

Quick facts

Lead sponsorUniversity of Seville
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment58
Start date24 April 2019
Primary completion27 September 2019
Estimated completion27 September 2019
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Seville

Who can join

Adults 18 to 40, any sex, with Neck Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objectives: To evaluate the clinical efficacy of using a manual inhibition technique for the suboccipital muscles compared with the use of the so-called INYBI tool in individuals with chronic non-specific neck pain, and the compare the results of using both approaches on pain relief, cervical range of motion neck and vertical maximum mouth opening. Design: Quantitative, experimental, longitudinal, prospective, and double blinded study. Subjects: Patients between 18 and 40 years, with chronic non-specific neck pain of at least 3 months of evolution. Methods: The experimental group will undergo a 5 minutes intervention for the suboccipital muscles using the INYBI tool. The control group will receive a 5 minutes of treatment involving the suboccipital muscles manual inhibition technique.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Neck Pain

Currently open trials in the same condition.

Other University of Seville trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03902119.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing